Cargando…

HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 sub-group analysis

INTRODUCTION: BMS-663068 is a prodrug of BMS-626529, an attachment inhibitor that binds directly to HIV-1 gp120, preventing initial viral attachment and entry into the host CD4+ T-cell. AI438011 is a Phase IIb, randomized, active-controlled trial investigating the safety, efficacy and dose–response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brinson, Cynthia, Lalezari, Jacob, Gulam, Latiff H, Thompson, Melanie, Echevarria, Juan, Treviño-Pérez, Sandra, Stock, David, Samit, Joshi R, George, Hanna J, Lataillade, Max
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Oral Presentation – Abstract O432A
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224901/ https://www.ncbi.nlm.nih.gov/pubmed/25394038 http://dx.doi.org/10.7448/IAS.17.4.19529

Ejemplares similares

Safety profile of HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 analysis
por: Lalezari, Jacob, et al.
Publicado: (2014)

540 HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Subgroup Analysis
por: Brinson, Cynthia, et al.
Publicado: (2014)

1574 Safety Profile of HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Analysis
por: Lalezari, Jacob, et al.
Publicado: (2014)

L'influence de la COVID-19 sur la santé mentale des enseignants Tunisiens
por: Ketata, N., et al.
Publicado: (2022)

Effet du décubitus ventral vigile chez des patients hospitalisés hors réanimation pour une pneumonie hypoxémiante à COVID-19 : un essai randomisé multicentrique
por: Nay, M.A., et al.
Publicado: (2023)

Viral Drug Resistance Through 48 Weeks, in a Phase 2b, Randomized, Controlled Trial of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir
por: Lataillade, Max, et al.
Publicado: (2018)

Het laatste woord
por: van Venrooij, Marleen
Publicado: (2020)

Wendbaarheid
por: van Meggelen, Marjolein
Publicado: (2020)

Passende communicatie
por: van Seggelen, Annemiek
Publicado: (2022)

365. Durable efficacy and robust CD4+ T-cell count improvement observed across age, race, sex, and geographic subgroups of heavily treatment-experienced people with multidrug-resistant HIV-1 after 240 weeks of fostemsavir treatment
por: Dyson, Alftan, et al.
Publicado: (2023)

Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals
por: Anderson, Sarah-Jane, et al.
Publicado: (2021)

Dapagliflozin: BMS 512148; BMS-512148
Publicado: (2012)

Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
por: Lamorde, M
Publicado: (2012)

Cases Reported by Surgeon R. D. Murray, M.B. B.M.S.
Publicado: (1878)

Evolution of resistance in paediatric patients with failure on antiretroviral therapy
por: Orrell, C, et al.
Publicado: (2012)

Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial
por: Morales-Ramirez, Javier, et al.
Publicado: (2018)

Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1
por: Ackerman, Peter, et al.
Publicado: (2021)

Infection à SARS-CoV-2 et biomédicaments : une étude multicentrique française de 7808 patients
por: Bataille, P., et al.
Publicado: (2020)

Impact de la COVID-19 sur les initiations et les renouvellements des biothérapies et traitements synthétiques ciblés en France
por: Richette, P., et al.
Publicado: (2020)

Analyse rétrospective des expositions enregistrée par les centres antipoison français pendant la première vague de COVID-19
por: Descatha, Alexis, et al.
Publicado: (2021)

Mort inattendue du nourrisson en lien avec une addiction maternelle au tramadol
por: Gaulier, Jean-Michel, et al.
Publicado: (2021)

Séroprévalence du SARS-CoV-2 chez 3845 patients atteints de rhumatisme inflammatoire chronique : résultats de la cohorte française COVID-RIC 1
por: Pham, T., et al.
Publicado: (2021)

L’infection a SARS-CoV-2 pourrait-elle induire des rhumatismes inflammatoires chroniques ? Une enquête nationale française
por: Marty-Ane, A., et al.
Publicado: (2021)

Le traitement par rituximab diminue la réponse humorale, mais pas la réponse cellulaire, après vaccination anti-SARS-CoV-2 chez des patients atteints de maladie auto-immune
por: Bitoun, S., et al.
Publicado: (2021)

Facteurs associés à la sévérité de l’infection COVID-19 chez les patients atteints de spondyloarthrite : résultats de la French RMD COVID-19 cohorte
por: Perrot, L., et al.
Publicado: (2021)

Facteurs de risque de réponse insuffisante à la vaccination contre la COVID-19 chez les patients traités par rituximab
por: Avouac, J., et al.
Publicado: (2021)

Caractéristiques cliniques de la Covid-19 chez les enfants et adolescents atteints de maladies rhumatismales et inflammatoires : données de la cohorte française RMD COVID-19 de 95 patients
por: Mammou Mraghni, S., et al.
Publicado: (2021)

Impact des JAK inhibiteurs sur la réponse vaccinale anti-SARS-CoV-2 : données du registre MAJIK-SFR
por: Seror, R., et al.
Publicado: (2021)

Hypométabolisme TEP cérébral chez les patients atteints de COVID long
por: Guedj, E., et al.
Publicado: (2021)

Brachial plexus neuropathies during the COVID-19 pandemic: A retrospective case series of 15 patients in critical care
por: O'Sullivan, J., et al.
Publicado: (2022)

Evaluation of patient reported outcomes following pain management programmes delivered via video conferencing during the Covid-19 pandemic
por: Heelas, L., et al.
Publicado: (2022)

The prevalence, location and severity of musculoskeletal pain following COVID-19
por: Briggs-Price, S., et al.
Publicado: (2022)

COVID-19: Physiotherapy students experience during practice placement in the United Kingdom
por: Haghighi, T., et al.
Publicado: (2022)

Musculoskeletal service transformation in a post-Covid world as part of the creation of a new city-wide single hospital service
por: Reid, D.
Publicado: (2022)

Embracing digital technology in response to the COVID - 19 pandemic: A patient satisfaction service evaluation
por: Hadley-Barrows, T., et al.
Publicado: (2022)

Physiotherapy staff experiences during COVID-19: A service evaluation, framework analysis and recommendations for a future physiotherapy service
por: James, S., et al.
Publicado: (2022)

A retrospective review of the use of text message communication for a musculoskeletal service during COVID-19
por: Waters, L., et al.
Publicado: (2022)

Pre-registration physiotherapy education in the COVID-19 era: A comparison of module results between students receiving traditional face-to-face or online-only education
por: Butcher, T., et al.
Publicado: (2022)

A mixed-methods survey to explore issues with virtual consultations for musculoskeletal care during the COVID-19 pandemic
por: Gilbert, A., et al.
Publicado: (2022)

A service evaluation of remote consultation mediums in a physiotherapy department during the COVID-19 pandemic
por: Harlington, S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6cq4isb5rvd5lcv9vocl75b8g2